Anti-β2GPI/β2GPI stimulates activation of THP-1 cells through TLR4/MD-2/MyD88 and NF-κB signaling pathways.

[1]  Hong Zhou,et al.  Anti-β(2)GPI/β(2)GPI induced TF and TNF-α expression in monocytes involving both TLR4/MyD88 and TLR4/TRIF signaling pathways. , 2013, Molecular immunology.

[2]  G. Valesini,et al.  Autoantibodies specific to a peptide of β2-glycoprotein I cross-react with TLR4, inducing a proinflammatory phenotype in endothelial cells and monocytes. , 2012, Blood.

[3]  S. Pierangeli,et al.  Pathogenesis of the Antiphospholipid Syndrome , 2012, Seminars in Thrombosis & Hemostasis.

[4]  I. Giles,et al.  Examining how antiphospholipid antibodies activate intracellular signaling pathways: a systematic review. , 2012, Seminars in arthritis and rheumatism.

[5]  K. McCrae,et al.  A novel pathway for human endothelial cell activation by antiphospholipid/anti-β2 glycoprotein I antibodies. , 2012, Blood.

[6]  J. Musial,et al.  Increased level of tumor necrosis factor-α in patients with antiphospholipid syndrome: marker not only of inflammation but also of the prothrombotic state , 2011, Rheumatology International.

[7]  H. Zhou,et al.  Toll‐like receptor (TLR)‐4 mediates anti‐β2GPI/β2GPI‐induced tissue factor expression in THP‐1 cells , 2011, Clinical and experimental immunology.

[8]  P. D. de Groot,et al.  Apolipoprotein E receptor 2 is involved in the thrombotic complications in a murine model of the antiphospholipid syndrome. , 2011, Blood.

[9]  N. Tsuchimori,et al.  TAK-242 (Resatorvid), a Small-Molecule Inhibitor of Toll-Like Receptor (TLR) 4 Signaling, Binds Selectively to TLR4 and Interferes with Interactions between TLR4 and Its Adaptor Molecules , 2011, Molecular Pharmacology.

[10]  Y. Shoenfeld,et al.  TLR2 Is One of the Endothelial Receptors for β2-Glycoprotein I , 2010, The Journal of Immunology.

[11]  F. Granucci,et al.  Deciphering the complexity of Toll-like receptor signaling , 2010, Cellular and Molecular Life Sciences.

[12]  D. Isenberg,et al.  Effects of Polyclonal IgG Derived from Patients with Different Clinical Types of the Antiphospholipid Syndrome on Monocyte Signaling Pathways , 2010, The Journal of Immunology.

[13]  M. Khamashta,et al.  Antiphospholipid syndrome: pathogenesis and a window of treatment opportunities in the future , 2010, European journal of clinical investigation.

[14]  N. Mackman,et al.  Role of tissue factor in thrombosis in antiphospholipid antibody syndrome , 2010, Lupus.

[15]  J. Chapman,et al.  Human antiphospholipid antibodies induce TNFalpha in monocytes via Toll-like receptor 8. , 2010, Immunobiology.

[16]  M. Lorenz,et al.  The Roll of Toll-like Receptors in the Antiphospholipid Syndrome , 2010, Current rheumatology reports.

[17]  K. Hajjar,et al.  Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. , 2009, Blood.

[18]  Hong Zhou,et al.  Annexin A2 mediates anti-β2GPI/β2GPI-induced tissue factor expression on monocytes , 2009 .

[19]  N. Mackman,et al.  Role of tissue factor in a mouse model of thrombotic microangiopathy induced by antiphospholipid antibodies. , 2009, Blood.

[20]  T. Kaisho,et al.  Analysis of binding site for the novel small‐molecule TLR4 signal transduction inhibitor TAK‐242 and its therapeutic effect on mouse sepsis model , 2009, British journal of pharmacology.

[21]  J. Brosens,et al.  ORIGINAL ARTICLE: Antiphospholipid Antibodies Induce a Pro‐Inflammatory Response in First Trimester Trophoblast Via the TLR4/MyD88 Pathway , 2009, American journal of reproductive immunology.

[22]  Yin Gao,et al.  TLR4-mediated MyD88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in cortex in mice. , 2009, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[23]  P. Pristovsek,et al.  Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin* , 2009, Journal of Biological Chemistry.

[24]  M. Karin,et al.  Regulation and function of NF-kappaB transcription factors in the immune system. , 2009, Annual review of immunology.

[25]  P. Meroni,et al.  Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome , 2008, Lupus.

[26]  C. Esmon.  Reprint of Crosstalk between inflammation and thrombosis , 2008 .

[27]  C. Le Quément,et al.  MMP-12 induces IL-8/CXCL8 secretion through EGFR and ERK1/2 activation in epithelial cells. , 2008, American journal of physiology. Lung cellular and molecular physiology.

[28]  D. Tanné,et al.  Interaction of inflammation, thrombosis, aspirin and enoxaparin in CNS experimental antiphospholipid syndrome , 2008, Neurobiology of Disease.

[29]  T. Takano,et al.  Tissue factor expression on monocytes induced by anti-phospholipid antibodies as a strong risk factor for thromboembolic complications in SLE patients. , 2008, Biochemical and biophysical research communications.

[30]  Hong Zhou,et al.  Involvement of annexin A2 in anti-β2GPI/β2GPI-induced tissue factor expression on monocytes , 2007, Cell Research.

[31]  G. Valesini,et al.  Anti-β2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor α and tissue factor by signal transduction pathways involving lipid rafts , 2007 .

[32]  Xiaowei Liu,et al.  Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies , 2007, Annals of the rheumatic diseases.

[33]  Makiko Kobayashi,et al.  Regulatory Roles for MD-2 and TLR4 in Ligand-Induced Receptor Clustering1 , 2006, The Journal of Immunology.

[34]  Y. Shoenfeld,et al.  International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS) , 2006, Journal of thrombosis and haemostasis : JTH.

[35]  Y. Shoenfeld,et al.  Infectious origin of the antiphospholipid syndrome , 2005, Annals of the rheumatic diseases.

[36]  K. McCrae,et al.  Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. , 2005, Blood.

[37]  A. Wolberg,et al.  Characterization of monocyte tissue factor activity induced by IgG antiphospholipid antibodies and inhibition by dilazep. , 2004, Blood.

[38]  C. Esmon.  Crosstalk between inflammation and thrombosis. , 2004, Maturitas.

[39]  I. Wicks,et al.  The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. , 2003, Arthritis and rheumatism.

[40]  L. O’Neill,et al.  Regulators of TLR4 signaling by endotoxins. , 2010, Sub-cellular biochemistry.

[41]  Y. Shoenfeld,et al.  Antiphospholipid Syndrome Infectious Origin , 2004, Journal of Clinical Immunology.